tony@wickedgraphics.com

InterVene Receives FDA 510(k) Clearance for Recana®, the First Fully Integrated Thrombectomy System for Venous In-Stent Restenosis and Native Vessel Obstructions

InterVene Receives FDA 510(k) Clearance for Recana®, the First Fully Integrated Thrombectomy System for Venous In-Stent Restenosis and Native Vessel Obstructions Recana is the first fully integrated platform designed for treating in-stent and native vessel obstructions. Recana Thrombectomy Catheter System is designed to address the challenges of venous in-stent restenosis and residual thrombotic obstructions and […]

InterVene Receives FDA 510(k) Clearance for Recana®, the First Fully Integrated Thrombectomy System for Venous In-Stent Restenosis and Native Vessel Obstructions Read More »

Irish hospital becomes first in world to trial new device to treat complex venous obstruction

Irish hospital becomes first in world to trial new device to treat complex venous obstruction Kelly Coughlin, the first patient in the world to receive treatment with the Recana Thrombectomy Catheter System, pictured with Prof Gerry O’Sullivan, consultant interventional radiologist at University Hospital Galway, following the successful procedure that represents a global breakthrough in the

Irish hospital becomes first in world to trial new device to treat complex venous obstruction Read More »

InterVene, Inc. Announces First Patient Treated With the Recana Thrombectomy Catheter System

InterVene, Inc. Announces First Patient Treated With the Recana® Thrombectomy Catheter System The Recana® System is Designed for the Treatment of Venous In-Stent Restenosis and Native Vessel Obstructions REDWOOD CITY, Calif., July 22, 2025 InterVene, Inc., a medical device company pioneering interventional devices for venous inflow and outflow obstructions, announced today that the first patient

InterVene, Inc. Announces First Patient Treated With the Recana Thrombectomy Catheter System Read More »